| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |